Evidence map›Paper›PMID 40755903›Full record

ArticleSurgical case reports2025

An Intrahepatic Cholangiocarcinoma Patient with von Willebrand Disease Successfully Treated with Robotic Hepatectomy under von Willebrand Factor Supplementation.

Hiroto Chiba, Naoya Sato, Hiroshi Takahashi, Yoshiki Suzuki, Takayasu Azuma, Shigeyuki Tsukida, Makoto Muto, Yasuhide Kofunato, Teruhide Ishigame, Takashi Kimura and 3 more

Abstract readCase Reports
In one paragraph

Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hiroto ChibaDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Naoya SatoDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Hiroshi TakahashiDepartment of Hematology, Fukushima Medical University, Fukushima, Fukushima, Japan.
Yoshiki SuzukiDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Takayasu AzumaDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Shigeyuki TsukidaDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Makoto MutoDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Yasuhide KofunatoDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Teruhide IshigameDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Takashi KimuraDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Akira KenjoDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Takayuki IkezoeDepartment of Hematology, Fukushima Medical University, Fukushima, Fukushima, Japan.
Shigeru MarubashiDepartment of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVon Willebrand disease (VWD) is the second most common inherited coagulation disorder, and appropriate perioperative management is necessary when considering major surgery. There are few reports of patients with VWD who have undergone hepatectomy, especially minimally invasive hepatectomy. To our knowledge, this is the first reported case of a patient with VWD who successfully underwent robotic hepatectomy with von Willebrand factor (VWF) and factor VIII (FVIII) supplementation. CASE PRESENTATION: A 75-year-old female was referred to our hospital because of a liver tumor that was diagnosed during follow-up after hepatitis C treatment. She had also been diagnosed with VWD in her 30s. CT and MRI showed a 24-mm mass in segment 8 of the liver, bordered by the middle hepatic vein (MHV). To ensure safe perioperative management, replacement therapy with a VWF- or FVIII-containing concentrate was administered from preoperative day 1 to POD 14. Robotic extended segmentectomy (segment 8) was performed, with resection of the MHV. Liver parenchyma was dissected using the crush and clamp technique under the Pringle maneuver. Estimated intraoperative blood loss was 160 mL, and total operative time was 601 min. The patient needed 2 units of fresh frozen plasma on POD 1; however, no other transfusions, including red blood cells, were required. Although the patient presented with postoperative ascites and was treated with diuretics, she was discharged on POD 20 without any bleeding event. The final pathological finding was intrahepatic cholangiocarcinoma.

conclusionsWe encountered a patient with intrahepatic cholangiocarcinoma and VWD who was successfully treated with anatomical hepatectomy by robotic-assisted laparoscopic surgery under perioperative replacement therapy with a VWF- or FVIII-containing concentrate. With appropriate perioperative management, major hepatectomy can be applied for VWD patients despite their high risk of postoperative hemorrhagic complications.

Indexed as

hepatectomyintrahepatic cholangiocarcinomavon Willebrand disease

Identifiers

PMID40755903
PMCPMC12318606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.